AABME is conducting a series of webinars to examine a risk-based, conceptual framework developed by the US Food and Drug Administration (FDA) for use at point-of-care manufacturing facilities. Webinar panels will include speakers from diverse groups, including medical device manufacturers, point-of-care manufacturers, technology developers, and the FDA. The framework includes the following scenarios: A. Minimal Risk 3DP by a Healthcare Professional B&C. Device Designed by Manufacturer Using Validated Process D. Manufacturer Co-Located at Point of Care E. Healthcare Facility Becomes a Manufacturer
Biomedical engineers are developing a number of techniques to 3D print corneal transplants to overcome shortages of donated corneas.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Researchers at the University of California, San Diego, created a 3D-printed spinal cord implant that help heal spinal injuries and markedly restores neural functioning. The implant shields neural progenitor cells while also directing orderly growth of axons.
Handheld BioPen filled with stem cells grows bone and cartilage to heal failing joints
Mechanical metamaterials offer new hope to orthopedic patients and their doctors by nearly eliminating degradation and damage to the hip socket.
A customizable drug implant could help automatically deliver the right amount of drugs over time to cancer patients.
Researchers have developed a 3-D printed patch that can deliver healthy cells to the heart after a heart attack.
Engineers have developed a new process of 3D bioprinting tissues that uses multiple cell-based inks to create more realistic structures in less time than previous methods.
Engineers have developed a new process of 3D bioprinting tissues that uses multiple cell-based inks to create more realistic structures in less time than previous methods.
Engineers convert a regular desktop 3D printer into a bioprinter for a fraction of the cost
Lorenzo Moroni and his team at University of Maastricht's Institute for Technology-Inspired Regenerative Medicine (MERLN) in The Netherlands, use 3D bioprinting to create "smart scaffolds," which they seed with patient stem cells and growth factors to produce structures that behave like natural cartilage tissues.
To a surgeon, a useful model organ needs to be more than a rigid plastic curio. It needs the feel of the real thing if it’s to be any good for practice. Now researchers have created a 3D printed organ with the elasticity of flesh and blood.
A new research paper reviews the current state of ventricular assist device (VAD) technology, summarizes advancements, and discusses complications and argues for development of alternatives for heart-failure therapy.
The orthopedic devices industry will continue to be a promising area in the global medical technology space, and is expected to rank third in sales after cardiology and in-vitro diagnostics by 2020. Read more about the market predictions from Frost & Sullivan.